The Latest Cardiac and Vascular News
The capital will be used to accelerate the commercialization of Prytime Medical’s new line of minimally invasive REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) hemorrhage control products. SAN ANTONIO, June 2, 2021 /PRNewswire/ — Prytime Medical Inc – The REBOA CompanyTM, is a leading innovator and global provider of life saving […]
STOCKHOLM, June 2, 2021 /PRNewswire/ — Betagenon AB, a Sweden-based biotech company focused on development of AMPK activator compounds, and MCG Technology Group Ltd, a Hong Kong-based biotech investment group, today announced that MCG Technology Group will invest in and collaborate with Betagenon. MCG Technology Group will invest 2M USD in exchange for Betagenon equity. Additionally, both […]
Former chief medical officer of MyoKardia to lead clinical development at Renovacor PHILADELPHIA and BOSTON, June 02, 2021 (GLOBE NEWSWIRE) — Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system (“CNS”) diseases resulting from BAG3 gene variants, today announced the appointment […]
SOUTH SAN FRANCISCO, Calif., June 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on May 31, 2021 it granted stock options to purchase an aggregate of 49,500 shares of common stock to eight new employees whose employment commenced in May 2021 as a material inducement to […]
MORRISVILLE, N.C., June 02, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resubmission for LIQ861 (treprostinil) inhalation powder to treat pulmonary arterial hypertension (PAH). The FDA confirmed that the resubmission was a complete, […]
On behalf of Cardiac Dimensions, please find key outcomes of the analysis “Percutaneous Mitral-Valve Annuloplasty Versus Optimal Medical Therapy in Patients with Secondary Mitral-Regurgitation and Severe Left-Ventricular Enlargement” published in this month’s JACC: Heart Failure. The manuscript can be viewed here: https://cardiacdimensions.com/wp-content/uploads/docs/Anker-Complete-Publication_May-2021.pdf Key outcomes of the analysis are as follows — in the Carillon […]
President and CEO Michael Coyle Steps Down Due to Personal Matters Douglas Devine to Serve as Interim CEO While Search for Permanent CEO is Conducted SAN FRANCISCO, June 01, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–HD Medical, Inc., the leader in cardiovascular disease (CVD) detection, today announces it has appointed Shaun Setty, MD, as its Chief Medical Officer (CMO). Dr. Setty is a cardiothoracic surgeon in Los Angeles, CA, with over 13 years of experience in pediatric and adult congenital cardiac surgery. […]
Further local deals are expected to take place in the course of the year LONDON, United Kingdom – ( BUSINESS WIRE ) – LivaNova PLC (NASDAQ: LIVN), a leader in medical technology and innovation, announced today that it has completed the initial completion of the divestment of its heart valve business (HV) to Gyrus […]
The First In Human implantation of the ICOMS FLOWMAKER® is assured following this financing BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, an Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced the […]
